XBiotech (XBIT) Change in Interest Receivables (2022 - 2025)
XBiotech (XBIT) posted quarterly Change in Interest Receivables of -$90000.0 for Q4 2025, down 200.0% year-over-year from $90000.0 in Q4 2024, and down 200.0% quarter-over-quarter from -$30000.0 in Q3 2025.
XBiotech (XBIT) Change in Interest Receivables (2022 - 2025) Analysis & Trends
XBiotech's Change in Interest Receivables history runs 4 years deep, the most recent figure standing at -$90000.0 for Q4 2025.
- In Q4 2025, Change in Interest Receivables fell 200.0% year-over-year to -$90000.0; the TTM figure through Dec 2025 stood at -$340000.0 (down 112.5% YoY), while the FY2025 annual figure was -$340000.0, down 112.5% from the prior year.
- Change in Interest Receivables for Q4 2025 stood at -$90000.0, down from -$30000.0 in the prior quarter.
- The five-year high for Change in Interest Receivables was $1.2 million in Q4 2022, with the low at -$2.3 million in Q3 2023.
- The 4-year median for Change in Interest Receivables is -$30000.0 (2024), against an average of $32727.3.
- The sharpest annual moves came in 2024 and 2025: Change in Interest Receivables jumped 94.01% in 2024, then slumped 2300.0% in 2025.
- XBiotech's Change in Interest Receivables stood at $1.2 million in 2022, then sank by 101.73% to -$21000.0 in 2023, then plunged by 42.86% to -$30000.0 in 2024, then slumped by 200.0% to -$90000.0 in 2025.
- Business Quant data shows XBIT's Change in Interest Receivables at -$90000.0 in Q4 2025, -$30000.0 in Q3 2025, and -$220000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Interest Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | XBiotech | 69.51 Mn | 69.51 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -90,000.00 |
| Sep 30, 2025 | -30,000.00 |
| Mar 31, 2025 | -220,000.00 |
| Dec 31, 2024 | -30,000.00 |
| Sep 30, 2024 | -140,000.00 |
| Mar 31, 2024 | 10,000.00 |
| Dec 31, 2023 | -21,000.00 |
| Sep 30, 2023 | -2.34 Mn |
| Jun 30, 2023 | 846,000.00 |
| Mar 31, 2023 | 1.16 Mn |
| Dec 31, 2022 | 1.22 Mn |